Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysis
European Journal of Neurology2021Vol. 28(10), pp. 3478–3490
Citations Over TimeTop 1% of 2021 papers
Tommaso Baldini, Gian Maria Asioli, Michele Romoli, Mariana Carvalho Dias, Eva C. Schulte, Larissa Hauer, Diana Aguiar de Sousa, Johann Sellner, Andrea Zini
Abstract
Cerebral venous thrombosis in the context of SARS-CoV-2 infection is a rare, although there seems to be an increased relative risk. High suspicion is necessary, because the diagnosis of this potentially life-threatening condition in COVID-19 patients can be challenging. Evidence is still scarce on the pathophysiology and potential prevention of COVID-19-associated CVT.
Related Papers
- → Effectiveness of different types of ultrasonography screening for developmental dysplasia of the hip(2020)11 cited
- → Local thrombolytic therapy in deep cerebral venous thrombosis(1997)72 cited
- → Thrombosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children: Retrospective Cohort Study Analysis and Review of the Literature(2023)8 cited
- → COVID-19-associated Isolated Cortical Vein Thrombosis: Detection of SARS‐CoV‐2 in CSF(2022)2 cited
- → Abstract WP180: Recanalization Predicts Prognosis After Cerebral Venous Thrombosis: A Systematic Review and Meta-analysis(2018)